ReviewPharmaceuticals (Basel, Switzerland)2021

COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection.

Katarzyna Kotfis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.